ELEVATE
Live / Applied — Statement of use — non-final action mailed (as of 10 Sept 2026)
What this means for you
Not registered yet, but its 14 Jan 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97219813
- Mark type
- Stylized text
- Filed
- 14 Jan 2022
- Published for opposition
- 06 Jun 2023
- Attorney of record
- Samantha C. Markley
Goods and services
- Class 001 — Chemicals: assays and reagents for use in genetic research; diagnostic reagents for scientific or research use; diagnostic reagents for clinical or medical laboratory use; reagents and reagent kits comprised primarily of nucleic acids, naturally occurring or modified nucleotides, enzymes, labels, and buffers, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulation, transcription, and expression for scientific research use, for diagnostic scientific use and for clinical laboratory research use
- Class 005 — Pharmaceuticals: medical diagnostic reagents; clinical medical diagnostic reagents; reagent kits and reagent beads with attached biomolecules, comprised primarily of oligonucleotides and other nucleic acids, natural and modified nucleotides, polypeptides, buffers, labels, and substrates, for clinical diagnostic purposes medical purposes
- Class 010 — Medical apparatus: clinical diagnostic instruments for medical use, namely, nucleic acid sequencers, imaging devices and analyzers
Owner
- Element Biosciences, Inc., San Diego, CA, US
- Element Biosciences, Inc., San Diego, CA, US
Prosecution history
- 10 Sept 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 10 Sept 2026 — NON-FINAL ACTION E-MAILED
- 10 Sept 2026 — SU - NON-FINAL ACTION - WRITTEN
- 20 Aug 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 30 Jul 2026 — USE AMENDMENT FILED
- 30 Jul 2026 — TEAS STATEMENT OF USE RECEIVED
- 17 Jun 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Jun 2026 — SOU EXTENSION 5 GRANTED
- 25 Jan 2026 — SOU EXTENSION 5 FILED
- 16 Jun 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 26 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 29 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Jul 2025 — SOU EXTENSION 4 GRANTED
- 28 Jul 2025 — SOU EXTENSION 4 FILED
- 28 Jul 2025 — SOU TEAS EXTENSION RECEIVED